Seller record · Telehealth service

PrescrYbe

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the GLP-1 page, the terms, the medical consent or the refund policy. 1 more criterion also fails; see the table below.

At a glance

PrescrYbeTelehealth service

6/8criteria passed

Price: Microdose semaglutide or tirzepatide $179 every 4 weeks; semaglutide injections $249 and tirzepatide injections $339 every 4 weeks
Sells: compounded semaglutide injections, compounded tirzepatide injections, and 6 more
FDA letters: None on file

Visit PrescrYbe See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth platform selling compounded semaglutide and tirzepatide injections, oral semaglutide and microdose plans on a four-weekly subscription, plus erectile dysfunction and testosterone treatment, prescribed by an outside clinical network and filled by four named partner pharmacies.

Operating entity Prescrybe Health, inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	PrescrYbe's GLP-1 page; PrescrYbe's terms and conditions
S2	Prescription gating	PASS	PrescrYbe's GLP-1 page; PrescrYbe's website; PrescrYbe's cancellation and refund policy
S3	Pharmacy identification	PASS	PrescrYbe's terms and conditions; PrescrYbe's privacy policy
S4	Compounding disclosure	PASS	PrescrYbe's GLP-1 page; PrescrYbe's medical consent
S5	Analytical documentation	FAIL	PrescrYbe's GLP-1 page; PrescrYbe's terms and conditions; PrescrYbe's medical consent
S6	Business address	FAIL	PrescrYbe's terms and conditions; PrescrYbe's privacy policy; PrescrYbe's cancellation and refund policy
S7	Price disclosure	PASS	PrescrYbe's GLP-1 page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe GLP-1 page says treatment plans are evaluated by board-certified clinicians through OpenLoop Health, and the terms say every clinical decision is made by independent licensed providers affiliated with its clinical partners, including OpenLoop Health and its affiliated professional entities.Source: PrescrYbe's GLP-1 page; PrescrYbe's terms and conditions.

S2PASSThe steps list a questionnaire about health goals and medical history first, and the answers say that a patient who qualifies on the eligibility quiz then starts the subscription and, after payment, completes a health history intake that the provider reviews.Source: PrescrYbe's GLP-1 page; PrescrYbe's website; PrescrYbe's cancellation and refund policy.

S3PASSThe terms name four licensed partner pharmacies with street addresses that may fill prescriptions: RedRock Pharmacy in St. George, Utah, Health Warehouse in Florence, Kentucky, Precision Compounding Pharmacy in Bellmore, New York and Triad Rx in Daphne, Alabama.Source: PrescrYbe's terms and conditions; PrescrYbe's privacy policy.

S4PASSThe footer of every page states that compounded medications are dispensed by state-licensed pharmacies but are not FDA approved, and the medical consent says compounded medications are not FDA-approved drug products.Source: PrescrYbe's GLP-1 page; PrescrYbe's medical consent.

S5FAILNo certificate of analysis or lot document is published on the GLP-1 page, the terms, the medical consent or the refund policy.Source: PrescrYbe's GLP-1 page; PrescrYbe's terms and conditions; PrescrYbe's medical consent.

S6FAILThe seller prints no street address of its own. The footer, the terms, the privacy policy and the refund policy carry only the company name, a support email and the addresses of its partner pharmacies.Source: PrescrYbe's terms and conditions; PrescrYbe's privacy policy; PrescrYbe's cancellation and refund policy.

S7PASSSemaglutide injections cost $249 every 4 weeks, tirzepatide injections $339, oral semaglutide $279, and microdose semaglutide or tirzepatide $179 every 4 weeks. An answer says the subscription covers coaching and clinical services and that the care team helps find the most affordable medication option.Source: PrescrYbe's GLP-1 page.

S8PASSNo FDA warning letter names PrescrYbe or Prescrybe Health, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injections, compounded tirzepatide injections, oral semaglutide, microdose semaglutide, microdose tirzepatide, sildenafil, tadalafil, testosterone replacement.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit PrescrYbe

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.